Keyphrases
Elderly Patients
100%
Response to Treatment
100%
Young Patients
100%
Age Spectrum
100%
Neovascular Age-related Macular Degeneration (nAMD)
100%
Subretinal Fluid
100%
Young Subgroup
50%
Statistical Significance
50%
Between-group
50%
Treatment Protocol
50%
Clinical Manifestations
50%
Genetic Factors
50%
Clinical Parameters
50%
Clinical Response
50%
Smoking History
50%
Choroidal
50%
Bilateral Involvement
50%
Systemic Factors
50%
Intravitreal Ranibizumab
50%
Number of Injections
50%
Pigment Epithelial Detachment
50%
Submacular Hemorrhage
50%
Polypoidal
50%
Pathophysiological Factors
50%
Medicine and Dentistry
Elderly Patient
100%
Optical Coherence Tomography
100%
Wet Macular Degeneration
100%
Bleeding
50%
Retrospective Study
50%
Heredity
50%
Bevacizumab
50%
Retinal Detachment
50%
Subretinal Fluid
50%
Nursing and Health Professions
Elderly Patient
100%
Optical Coherence Tomography
100%
Wet Macular Degeneration
100%
Bleeding
50%
Bevacizumab
50%
Retina Detachment
50%
Subretinal Fluid
50%
Biochemistry, Genetics and Molecular Biology
Liquid
100%
Genetic Determinism
50%
Retrospective Study
50%
Bevacizumab
50%
Neuroscience
Bevacizumab
100%
Age-Related Macular Degeneration
100%